Epigenetic Markers May be Used to Estimate Anal Cancer Risk

News   May 31, 2017 | Original story from Queen Mary University London

 
Epigenetic Markers May be Used to Estimate Anal Cancer Risk

Microscope image of abnormal cells within the anus. Credit: QMUL

 
 
 
 

RELATED ARTICLES

CRISPR Reveals New Targets for Promising Cancer Drugs

News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

READ MORE

DARPA Pours $65 Million Into Making CRISPR Safer

News

With one eye on potential bioterrorism threats, the Defense Advanced Research Projects Agency has announced $65 million in funding to seven projects around the USA.

READ MORE

Potential Barcode Identified for a Form of Alcoholic Liver Disease

News

NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE